Phase II trial of gefitinib inpatients with incurable salivary gland cancer.

被引：0
|
作者：
Glisson, BS [1 ]
Blumenschein, G [1 ]
Francisco, M [1 ]
Erasmus, J [1 ]
Zinner, R [1 ]
Kies, M [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508S / 508S
页数：1
相关论文
共 50 条
  • [41] A pilot phase II trial of cabergoline in the treatment of metastatic breast cancer.
    Costa, Ricardo Lima Barros
    Santa-Maria, Cesar Augusto
    Scholtens, Denise M.
    Jain, Sarika
    Gradishar, William John
    Clevenger, Charles V.
    Kaklamani, Virginia G.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial
    Jakobsen, Anders
    Andersen, Fahimeh
    Fischer, Anders
    Jensen, Lars H.
    Jorgensen, Jens C. R.
    Larsen, Ole
    Lindebjerg, Jan
    Ploen, John
    Rafaelsen, Soren R.
    Vilandt, Jesper
    ACTA ONCOLOGICA, 2015, 54 (10) : 1747 - 1753
  • [43] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [44] Phase II trial of palbociclib in patients with advanced esophageal or gastric cancer.
    Karasic, Thomas Benjamin
    O'Hara, Mark H.
    Teitelbaum, Ursina R.
    Damjanov, Nevena
    Giantonio, Bruce J.
    d'Entremont, Tracy S.
    Gallagher, Maryann
    Zhang, Paul J.
    O'Dwyer, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [45] A phase II trial of celecoxib, irinotecan, and capecitabine in metastatic colorectal cancer.
    El-Rayes, BF
    Zalupski, MM
    Shields, AF
    Heilbrun, LK
    Bekaii-Saab, T
    Vaishampayan, U
    Philip, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 290S - 290S
  • [46] Phase II trial of irinotecan/docetaxel combination for advanced pancreatic cancer.
    Burtness, B
    Sipples, R
    Mirto, G
    Thomas, L
    Ahman, ZA
    Kloss, RA
    Murren, J
    Lacy, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 342S - 342S
  • [47] Phase II trial of temsirolimus and bevacizumab for initial recurrence of endometrial cancer.
    Einstein, Mark H.
    Wenham, Robert M.
    Morgan, Robert
    Cristea, Mihaela C.
    Strevel, Elizabeth Laureen
    Oza, Amit M.
    Kaubisch, Andreas
    Fruth, Briant
    Qin, Rui
    Erlichman, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer.
    Cho, CD
    Fisher, GA
    Halsey, J
    Jambalos, CN
    Schwartz, EJ
    Rouse, RV
    Advani, RH
    Wakelee, HA
    Lum, BL
    Sikic, BI
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6103S - 6103S
  • [49] A phase II study of gefitinib in combination with FOLFOX-4 (IFOX) in patients with metastatic colorectal cancer.
    Fishe, GA
    Kuo, T
    Cho, CD
    Halsey, J
    Jambalos, CN
    Schwartz, EJ
    Robert, RV
    Advani, RH
    Wakelee, HA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 248S - 248S
  • [50] Phase II Trial of Docetaxel Chemotherapy in Patients with Incurable Adenocarcinoma of the Esophagus
    Elisabeth I. Heath
    Susan Urba
    John Marshall
    Steven Piantadosi
    Arlene A. Forastiere
    Investigational New Drugs, 2002, 20 : 95 - 99
12345